EVOTEC AND APEIRON BIOLOGICS TO DISCOVER NOVEL PAIN THERAPEUTICS
Evotec AG and Apeiron Biologics GmbH today announced that they have entered into
a discovery collaboration to develop small molecules targeting a novel therapeutic
concept for pain relief. This concept is based on research activities of Prof
Josef Penninger, Director of the Institute for Molecular Biotechnology of the
Austrian Academy of Sciences (IMBA).
Oxfordshire Bioscience Network